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Keratinocyte Differentiation in Acquired 
Cholesteatoma and Perforated 
Tympanic Membranes
Paul P, C. A. Vennix, MDt; Wim Kuijpers, PhD; Theo A. Peters;
Edith L G. M. Tonnaer, MA; Frans C. S. Ramaekers, PhD
Objective* To evaluate the type of differentiation of ke- 
ratinocytes of acquired cholesteatoma and its signifi­
cance for cholesteatoma invasiveness.
Design: Forty acquired cholesteatomas and 10 tym­
panic membranes with persisting perforations were snap 
frozen and processed for immunohistochemical stud­
ies. Cytokeratin antibodies that represented all sub­
groups and antibodies that were directed against colla­
gen components of the basal lamina were applied. 
Expression of these constituents was scored by using light 
microscopy.
Results: The phenotype of the matrix was generally char­
acterized by an extension of expression of basal cell cy­
tokeratin 14 and hyperproliferation-associated cytoker- 
atins 6,16, and 17 into the suprabasal cell layers, while 
the expression of keratinization marker cytokeratin 10 
was down-regulatecL These features varied greatly at dif- 
ferent sites of the matrix and were most marked at the 
advancing front of the cholesteatoma. A comparable ex­
pression pattern, but less pronounced, was observed at 
the epidermal front of the mucocutaneous junction of the 
tympanic membrane perforations, This phenomenon was 
invariably associated with a mononuclear cell infiltrate 
in the dermis at both junctions. The basal lamina was al­
ways intact.
Conclusions: Acquired cholesteatomas show hyperpro- 
liferative features. There is a striking similarity between 
the pronounced expression of this phenotype and the as­
sociated inflammation at the mucocutaneous junctions 
of cholesteatomas and tympanic membrane perfora­
tions and those that are observed after epidermal injury, 
This indicates that epidermis and middle ear epithelium 
do not form stable junctions and the front can be con­
sidered to be a persisting epidermal defect. This in­
volves the permanent presence of "activated keratino- 
cytes” in the junction area that will lead to proliferation 
and migration, when additional triggers are present,
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N o t o l o g y ,  the differentiation- 
dependent expression patterns of 
the cytokeratins (Cks) 1"4 have 
been used to shed light on the 
con tinu ing  d iscussion  about 
whether cholesteatomas originate exclu­
sively from the m eatal ep iderm is or 
whether they can also be the result of squa­
mous metaplasia of the middle ear epithe­
lium. The expression of mainly epider­
mal Cks in cholesteatoma was generally 
considered to reflect an epidermal ori­
gin .3'8 The focal expression of nonepider- 
mal Cks observed in some specimens has 
been explained in different ways. Broekaert 
et aF and Vennix et al7 explained that the 
expression of these “ectopic Cks1* could be 
the result of a local state of hyperprolif­
eration or the result of the modulating ef­
fect of the middle ear mesenchyma,9 while 
van Blitterswijk et al6 have considered 
metaplasia as the possible cause.
During recent years, hyperprolifera­
tion-associated Ck 16 has been studied in 
an attempt to explain the expansive be­
havior of cholesteatomas.10'12 However, the 
results of these studies varied consider­
ably, even when the same antibodies were 
applied. These discrepancies have to be as­
cribed to the application of poorly char­
acterized antibodies11,12 and to the study 
of ill-defined parts of the matrix. In addi­
tion, the mere presence of Ck 16 in cho­
lesteatoma does not necessarily indicate a 
hyperproliferative condition of the ma­
trix, because this Ck has also been dem­
onstrated in normal deep meatal skin.13,14
In a recent study,14 we observed a 
mixed differentiation phenotype in deep 
meatal skin that is not found in normal
See
on
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MATERIALS A N D  METHODS
All the specimens that were used in this study were 
obtained during ear surgery. These specimens com­
prised (1) 10 tympanic membranes with persisting 
partial or subtotal perforations from dry ears with­
out cholesteatoma and (2) 40 acquired cholesteato­
mas of varying size with tympanic membrane perfo­
rations.
Immediately after dissection, the specimens were 
frozen in liquid nitrogen and stored at — 70°C Cryo­
stat sections (7 fxm) were placed on poly-L-lysine- 
coated slides, dried in a cold airstream for 30 minu tes, 
and stored at — 70°C until required Immunostaining 
was performed by using a previously described indi­
rect immunoperoxidase technique.7 The antibodies that 
were applied and their characteristics are indicated in 
the Table.
skin. In addition to the typical epidermal expression pat­
tern, characterized by the presence of Ck 10 in the su­
prabasal cells, hyperproliferation-associated Cks 6 , 16, 
and 17 were expressed parabasally, while Ck 19 was ex­
pressed in the basal cells. This phenotype, which only 
partly coincided with the areas of proliferative activity, 
was assumed to be associated with the unique pattern of 
keratinocyte migration, which was needed to keep this 
part of the meatus free from desquamation products.
The aim of the present immunohistochemical study 
was to define further the types of differentiation in the 
matrix of acquired cholesteatoma. Special attention was 
paid to the expression of hyperproliferation-associated 
Cks and their interrelationship with the expression of 
other Ck subgroups in well-defined areas of the matrix, 
including the advancing front. For comparison, the mu­
cocutaneous junctions of persisting tympanic mem­
brane perforations were also evaluated.
CHOLESTEATOMA MATRIX
The matrix consisted of keratinizing epithelium with lo­
cal variations in thickness, The underlying stroma was 
composed of loose connective tissue that contained cap­
illaries and varying numbers of lymphocytes, plasma cells, 
and macrophages. These features varied considerably be­
tween specimens and within the same specimen.
The Ck expression patterns showed variations within 
and between specimens (Figure 1). These patterns could 
roughly be divided into the 3 types that are presented dia­
grammatic ally in Figure 2 .
Type 1 showed homogeneous expression of basal 
cell Cks 5 and 14 in the basal cell layer, while Ck 14 ex­
pression could also extend into 1 or more suprabasal lay­
ers. Incidentally, the basal cells showed sparse expres­
sion of Ck 19, All suprabasal cell layers showed expression 
of keratinization marker Ck 10. Hyperproliferation- 
associatecl Cks 16 and 17 revealed focal to hetero­
geneous expression in the parabasal cell layer, while Ck 
6 was homogeneously expressed in a varying number of 
suprabasal layers and in nearly all basal cells. In the stroma, 
no or only a few scattered inflammatory cells were ob­
served.
In the type 2 profile, Ck 19 was completely absent. 
Cytokeratin 5 was expressed in scattered basal cells, while 
the other basal cell marker Ck 14, besides being ex­
pressed in the basal cells, extended into all suprabasal 
cell layers. Hyperproliferation-associated Ck 6 was ex­
pressed in all cell layers, while Cks 16 and 17 were found 
in a varying number of suprabasal cell layers; Ck 17 ex­
pression was usually less marked than that of Ck 16, There 
was no expression of keratinization marker Ck 10 in 1 
or more suprabasal cell layers. In the underlying stroma, 
scattered inflammatory cells were always observed.
In the type 3 profile, Ck 19 and basal cell Ck 5 were 
not expressed, while the other basal cell marker Ck 14 
and hyperproliferation-associatecl Ck 6 were expressed 
in all cell layers, and Cks 16 and 17 were expressed in 
all suprabasal cell layers, with Ck 10 absent or only ex­
pressed in the outermost cell layers. In 2 of 40 choles­
teatoma specimens, limited areas of the matrix showed 
scattered keratinocytes that expressed the stratification 
markers of noncornifying epithelia (ie, Cks 4 and 13), 
as well as vimentin. This profile, which was only ob­
served rarely in the matrix, was often associated with dis­
tinct basal cell hyperplasia, parakeratosis, dense accu­
mulations of inflammatory cells, and many capillaries in 
the stroma. These latter features were detected with vi­
mentin and collagen IV staining. The staining patterns 
for collagens IV and VII indicated that the basal lamina 
was always intact.
CHOLESTEATOMA FRONTS
The epidermal fronts that were found in the large ma­
jority of specimens either penetrated into the stroma 
(Figure 3, A) or were situated on top of it in contact 
with the middle ear epithelium (Figure 3, B and C; 
Figure 4; and Figure 5, C). They showed a varying de­
gree of hyperplasia and dysplasia and papillary in ­
growth into the stroma and were frequently found to have 
undermined the middle ear epithelium (Figure 3, B; Fig­
ure 4, K~N; and Figure 5, C) or to have migrated on top 
of it. The adjacent middle ear epithelium showed hyper­
plasia (Figure 4 and Figure 5, C). Morphologically har­
monious junction areas that showed only slight hyper­
plasia were also observed incidentally (Figure 3, C). The 
lamina propria at the junction areas contained many cap­
illaries and invariably showed the presence of large ac­
cumulations of inflammatory cells that were mainly lo­
cated ahead of the front (Figure 5, A) and often were 
associated with local disruption of the middle ear epi­
thelium (Figure 3, B).
Based on their Ck expression profile, 2 different 
phenotypes were identified in the advancing fronts 
that could both be present within the same specimen. 
The first phenotype (Figure 4, A, C, E, G, I, K, and M) 
showed a similar Ck expression pattern to that of the 
type 3 profile of the cholesteatoma matrix: Ck 19 (Fig­
ure 4, M) and Ck 5 were absent, but all cell layers
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showed Ck 14 expression (Figure 4, A). From the 
hyperproliferation-associated Cks, Ck 6 (Figure 4, G) 
was expressed in all cell layers, and Cks 16 (Figure 4, 
E) and 17 w ere expressed in  all suprabasal cells. 
Expression of Ck 10 (Figure 4, C) was absent or lim­
ited to the upperm ost cell layers. No reaction was 
observed with the markers of simple epitheiia or with 
the stratification markers of noncornifying epitheiia 
(Figure 4 , 1 and K).
The expression patterns of Cks 6 , 16, and 14 (Fig­
ure 4, H, F, and B, respectively) in the second pheno­
type (Figure 4, B, D, F, H, J, L, and N) were similar to 
those observed in the first phenotype, but the upper cell 
layers expressed both keratinization marker Ck 10 (Fig­
ure 4, D) and the stratification markers of noncornify- 
ing epithelium Cks 4 and 13 (Figure 4, L an d j, respec- 
lively). In addition, the simple epithelial cell marker Ck 
19 (Figure 4, N) was expressed heterogeneously in the 
basal and suprabasal cell layers. Cytokeratin 6 was ab­
sent in the Ck 19-positive basal cells, while scattered cells 
that expressed simple epithelial Cks 7, 8, and 18 were 
observed incidentally in the superficial layers. Staining 
with vimentin antibodies was observed in scattered Ice- 
ratinocytes in 2 specimens. Morphologically, the junc­
tion areas of the second phenotype were characterized 
by the presence of dysplasia.
In the junction area of the cholesteatoma front, 
the hyperplastic m iddle ear epithelium  showed an 
increased expression of basal cell markers Cks 5 and 
14, the s tra tifica tio n  m arkers Cks 4 and 13, and 
hyperproliferation-associated Cks 6 and 17 in com­
parison with those of the normal epithelium. There 
was no Ck 16 expression. The antibodies that were 
directed against collagen types IV and VII revealed 
that the basal lamina was continuous in all the speci­
mens (Figure 5, A).
Fig u re  1 .  Survey of cholesteatoma matrix shows widely divergent 
expression patterns of the hyporprollferatlonsssoc/ated cytokeratin 16 at 
different sites (x 5 0 ).
TYMPANIC MEMBRANE PERFORATIONS
In 6 specimens of the 10 tympanic membrane perfora­
tions that were studied, the epidermis ended at some dis­
tance from the perforation edge, and the middle ear epi­
thelium was covering part of the lateral surface of the 
tympanic membrane (Wfliire 6 , B). In 4 specimens, the 
mucocutaneous junction coincided with the perfora­
tion edge (Figure 6 , A).
The front of the thickened epidermis frequently
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Figure 2 .  Diagram o f the different expression patterns of cytokerattns (Cks) In basal and suprabasal cell layers of cholesteatoma matrix (types 1-3). For 
comparative purposes, the Ck expression of the normal epidermis and epidermis of cartilaginous and osseous meatus have been Included,
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Figure 3 .  Immunohistochemical staining o f cholesteatoma fronts. A, Cholesteatoma front penetrating into the stroma. Note the expression of basal cell 
cytokeratin 14 in all cell layers of the front while expression in the matrix distant from the front is limited to the basal and parabasal ceil layers. B, 
Cholesteatoma front undermining the middle ear epithelium, reactive for cytokeratin 8 (arrowheads). Note the accumulation of inflammatory cells (arrow) at 
the junction and local disruption of the middle ear epithelium. C, Cholesteatoma front with a morphologically stable mucocutaneous junction and dermal 
accumulation of Inflammatory ceils (arrow) Immunostained for cytokeratin 10. In comparison with the fronts In A and B} there is less hyperplasia, The 
keratinization marker cytokeratin 10 Is absent in the parabasal cell layer (x 5 0  [A, B], x 1 8 0  [C]).
showed basal projections into the connective tissue 
(Figure 6), The adjacent middle ear epithelium was 
composed of a normal flat to cuboidal epithelium, 
which could be clearly distinguished from the epider­
mal cells on the basis of their different Ck expression 
patterns. There was a gradual transition between both 
types of epithelium in all of the specimens (Figure 6, 
C)> No undermining or overgrowth of the middle ear 
epithelium  by the epidermis was observed. At the 
mucocutaneous junction, the lamina propria invari­
ably contained a d istinc t accum ulation of m ono­
nuclear inflammatory cells (arrows in Figure 6 , A, B, 
and D) and many capillaries (Figure 5, B).
The epidermal front revealed a weak focal to heter­
ogeneous expression of basal cell Ck 5 (Figure 6 , E), while 
Ck 14 was expressed in all cell layers (Figure 6 , F). Ex­
pression of Cks 6,16, and 17 (Figure 6, H, 1, and J, re­
spectively) extended into a varying num ber of su­
prabasal cell layers. Cytokeratin 10 (Figure 6 , G) was 
absent in 1 to 2 parabasal cell layers, identical to type 2 
Ck expression in the cholesteatoma matrix.
The epidermis in the remaining part of the tym­
panic membrane showed a weak, nearly homogeneous 
expression of Ck 5 in the basal cell layers and a strong 
expression of Ck 14 in the basal and parabasal ceil lay­
ers (Figure 6 , E and F, respectively). Cytokeratin 10 was 
expressed in all suprabasal cell layers (Figure 6 , G), while 
Ck 19 wAs present focally in the basal cells. Hyperpro­
liferation-associated Ck 6 was expressed in 2 or more su­
prabasal cell layers (Figure 6, H), while Cks 16 and 17 
showed only weak focal expression in the parabasal cell 
layer (Figure 6, I and J). The Ck profile of the middle
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Figure 5* A , Mucocutaneous Junction o f cholesteatoma, stained for 
colfBgen IV, shows continuity o f the bass! lamina and m any capillaries in 
the Inflamed Junction area, 8 ; Mucocutaneous junction at the edge of a 
tympanic membrane perforation stained fo r collagen I V  shows continuity 
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X 180 [C ]),
ear epithelium did no t differ from that of normal speci­
men s> The antibodies that were directed against colla- 
gens IV and VII always dem onstrated a continuous basal 
lamina (Figure 5, B and Figure 6 , D)
(  O M M I M
The Ck profile of the matrix of acquired cholesteatoma 
basically shows the same features as those of the epider­
mis of the deep part of the external m eatus14 (ie, the ex-
pression of both epidermal and hyperproliferation- 
associated Cks). However, the levels of expression reflect 
a more hyperproliferative phenotype. The expression of 
Ck 19 and basal cell Ck 5 is severely reduced or absent 
in the basal cells of the cholesteatoma matrix. In the su- 
prabasal cells, there is down-regulation of keratiniza- 
tion marker Ck 10 and up-regulation of basal cell Ck 14 
and hyperproliferation-associated Cks 6,16, and 17. These 
changes in the Ck profile indicate an altered process of 
differentiation and result in a phenotype that is similar 
to that observed after skin injury,27 in hyperprolifera­
tive skin disease,28,29 and in malignant transforma­
tion.1,28 The Ck pattern indicates the presence of a hy­
perproliferative condition, but it can differ widely between 
individual specimens and at various sites within the same 
specimen. The dissociation between the expression of 
basal cell markers Cks 5 and 14 is remarkable. This phe­
nomenon has also been observed in psoriasis.29
The hyperproliferative phenotype is most pro­
nounced at the advancing front of cholesteatoma. The 
additional expression of nonepidermal Cks and vimen- 
tin in a proportion of the fronts appears to be related to 
dysplasia. This demonstrates that the presence of non­
epidermal Cks, which are also observed incidentally in 
small areas of the matrix, does not necessarily refer to a 
metaplastic origin of the cholesteatoma, as suggested pre­
viously.6
These events at the advancing fronts indicate se­
vere disregulation of normal epidermal differentiation and 
proliferation and provide further evidence to support the 
suggestion that the front area is the most important site 
of matrix expansion. However, the present observations 
do not confirm that the expansion is associated with a 
distortion of the basal lamina.30 In the major part of the 
matrix outside the front, the hyperproliferative condi­
tion is less marked. This indicates that once the matrix 
has formed, there is a tendency to return to the native 
phenotype.
The invariable presence of a mononuclear cell in­
filtrate at the advancing front reflects a close relation­
ship between the hyperproliferative condition and a 
chronic inflammatory process. The presence of inflam­
matory cells at the mucocutaneous junction of the cho­
lesteatoma matrix has been reported previously,30 and has 
been suggested to be owing to the irritating effect of kera­
tin at the junction or to the lack of a tight seal, allowing 
microorganisms to enter the dermis. It was concluded30 
that the inflamed stroma, rather than the inherent char­
acteristics of the squamous epithelium, determined the 
invasive nature of the cholesteatoma.
Although there is no doubt that inflammation or in­
fection are important causal factors in cholesteatoma gen­
esis, the answer to the question of whether epidermis and 
middle ear epithelium can form a stable junction ap­
pears to be of more importance for explaining the inva­
sive nature of cholesteatoma. Animal studies have shown 
that meatal skin transplants can grow in the middle ear, 
although differentiation of the keratinocytes seems to be 
modulated by the stroma of the middle ear.9 However, 
data that have been reported on the character of the junc­
tion between epidermal cells and middle ear epithelium 
have been contradictory.9*30
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response to a large variety of injurious stimuli.31'34 They 
then start to express hyperproliferation-associated Cks, 
change their adhesive properties, and become migra­
tory. In addition, they produce and respond to immu­
nological signals (eg, cytokines and epidermal growth fac­
tors). Cytokines can th e n  induce  the attraction of 
inflammatory cells from the circulation and promote their 
migration toward the site of injury. This cascade of events 
can also be assumed to occur at the mucocutaneous junc­
tions of tympanic m em brane perforations and choles­
teatomas. At these sites, it will become a continuing pro­
cess because epidermal homeostasis cannot be restored.
Although this condition can be considered as the 
main underlying cause of m atrix propagation, the exist­
ence of apparently stable junctions at the perforation edge 
and epidermal expansion at the cholesteatoma front needs 
further explanation. This study shows that there is 110 
qualitative difference between the reactions at the 2 junc­
tions, but that the hyperproliferative condition and the 
intensity of the inflam m atory process are more pro­
nounced at the cholesteatoma front. Therefore, we must 
assume that there are additional injurious stimuli that 
enhance this reaction and disturb the “stable” equilib­
rium between the epidermis and middle ear epithelium 
at the cholesteatoma junction. One can only speculate 
about the nature of these stimuli, which may also be re­
sponsible for the induction of the pronounced hyper­
proliferative phenotype in parts of the matrix. The en­
vironmental conditions (eg, humidity, accumulated 
cellular debris, and desquamation products) in the middle 
ear that can promote inflam m ation or infection are the 
most likely candidates.
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